VINCENT GOLIK: Open Payments
NPI 1104226547 · IRWIN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 118 payments from 19 companies in 2025. Trend: 2023 $2,417 · 2024 $2,099 · 2025 $1,886
Food & beverage: $1,886
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $252 |
| AstraZeneca Pharmaceuticals LP | 4 | $246 |
| ABBVIE INC. | 24 | $222 |
| GlaxoSmithKline, LLC. | 11 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $150 |
| Novo Nordisk Inc | 12 | $149 |
| Lilly USA, LLC | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $130 |
| Exact Sciences Corporation | 5 | $103 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: BREZTRI, NURTEC ODT, JARDIANCE, QULIPTA, CAPLYTA, TRELEGY ELLIPTA, TRINTELLIX, ELIQUIS.
Industry payments across PA — which companies pay providers there.
